Search Results 171-180 of 16691 for Bacitracin

  1. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.

  2. Doxorubicin Hydrochloride, Cyclophosphamide, And Paclitaxel With Or Without Bevacizumab In Treating Patients With Lymph Node-Positive Or High-Risk, Lymph Node-Negative Breast Cancer - Mayo Clinic

    Bevacizumab may also stop the growth of breast cancer by blocking blood flow to the tumor. Giving chemotherapy after surgery may kill any tumor cells that ...

  3. A Study Comparing The Efficacy, Safety And Tolerability Of Fixed Dose Combination (FDC) Of FF/UMEC/VI With The FDC Of FF/VI And UMEC/VI; Administered Once-daily Via A Dry Powder Inhaler (DPI) In Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

    A Study Comparing The Efficacy, Safety And Tolerability Of Fixed Dose Combination (FDC) Of FF/UMEC/VI With The FDC Of FF/VI And UMEC/VI; ...

  4. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  5. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

    The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. Participation eligibility.

  6. A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea - Mayo Clinic

    608 patients with Clostridium Difficile Associated Diarrhea (CDAD) will participate in this study and receive either oral vancomycin or CB-183,315 in a blinded ...

  7. Clinical trials - Oncology (Medical)

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...

  8. A Study of Cemiplimab in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy - Mayo Clinic

    The primary objective is to estimate the overall response rate (ORR) for metastatic Basal Cell Carcinoma (BCC) (group 1) and for unresectable locally advanced ...

  9. Lapatinib (oral route) - Side effects & dosage - Mayo Clinic

    Lapatinib is used in combination with capecitabine to treat advanced or metastatic (cancer that has already spread) HER2-receptor positive breast cancer in ...

  10. Pediatrics Clinical Trials - Medical Professionals

    Rochester, Minn. This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility ...